GLP-1 (Glucagon-like Peptide-1) is a hormone that regulates blood sugar and appetite
Per the FY2026 ICD-10-CM Official Guidelines Section I.C.14, the CKD stage code is sequenced first
(3) Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R and Jones R (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
People who stop taking the medication often gain back some or most of the weight unless they maintain strong lifestyle habits
Clinical trials report an average of 1215% body weight reduction in patients using GLP-1 drugs like Wegovy and Mounjaro
We began by defining skin sensitivity and its common symptoms, such as redness, itching, and irritation